These results demonstrate the importance of colonization with S. aureus in Atopic Dermatitis... At present, new targeted antimicrobial therapies (such as lysins) are being developed, which are directed against single bacteria (e.g. Staphefekt SA.100 against S. aureus).
Prevalence and odds of Staphylococcus aureus carriage in atopic dermatitis: a systematic review and meta-analysis
Share this article
Bekijk een volgend artikel
Staphefekt is featured in The Biomedical Scientist as being the first effective alternative to antibiotics for suppression of S. aureus on the skin.
Staphefekt – intervening early in the Colonisation Infection Continuum with endolysins